Paper Diagnostics Market

Market Overview

The global paper diagnostics market size was valued at USD 8 billion in 2021, and it is anticipated to reach USD 16.17 billion by 2030 at a CAGR of 8.13%.

Paper diagnostics are a series of diagnostic procedures that can be carried out with inexpensive, user-friendly, and dependable instruments in regions where more modern diagnostic techniques may not be accessible or affordable. Paper diagnostics might be a great alternative to advanced diagnostic technology in remote areas where trained staff is required. However, advanced diagnostic equipment can be an excellent solution if trained staff is not available.

Paper diagnostics operate according to the same concept as litmus or pH paper. A chemical reaction between the coating on the paper and the substance to be tested generates a distinctly visible result that may be utilized for diagnosis. In other words, paper diagnostics work in the same way that litmus or pH paper does. Paper diagnostics allow even inexperienced patients to interpret the results because explicit directions are provided regarding the meaning of each visible result. Due to this, individuals with diseases that necessitate routine self-diagnosis constantly need paper diagnoses.

Market Dynamics

Global Paper Diagnostics Market Drivers

• The Rise in the Incidence of Autoimmune Disorders Is Driving Growth

There has been an increase in the number of persons diagnosed with cancer and autoimmune illnesses and an increase in awareness of the different alternatives available for a quick and timely diagnosis. Since 1988, the frequency of autoimmune illnesses in the United States has progressively increased, reaching 11.5% in 1999-2004 and 15.9% in 2011-2012, a report from the National Institutes of Health (NIH) found in April 2020.

Paper diagnostics offer promising options for the early diagnosis of various diseases, focusing on the most important components of the diagnosis procedure and outcomes, such as cost-effectiveness, mobility, sustainability, and the capacity to be thrown away after use. The results of the National Institutes of Health's (NIH) National Health and Nutrition Examination Survey (NHANES) indicate that the prevalence of autoimmune disorders in the United States is expected to increase even further in the years ahead. The evidence suggests that there will be a significant increase in demand for paper diagnostics during the next few years.

• Rising incidence of diseases that can be diagnosed via the use of paper diagnostics

The rising incidence of disorders that can be identified or tracked via paper diagnostics is the key factor propelling growth in the global market for paper diagnostics. An essential factor propelling growth in the global market for paper diagnostics is the increasing incidence of chronic diseases such as diabetes. Paper diagnostics allow for successful self-monitoring of diabetes, removing the requirement for expensive hospital visits and tests. It frees up significant financial resources.

The global market for paper diagnostics has been spurred forward by several factors, including the rising incidence of liver illnesses, infectious diseases, and cancer. Demand for point-of-care testing, which in turn drove demand for paper diagnostics, was driven by the increased number of patients suffering from these diseases in remote places. The growing amount of environmental pollution is another factor contributing to the rise in the incidence of these diseases.

The rising demand for paper diagnostics can be attributed partly to the great dependability of these tests, which can be achieved at costs significantly lower than those of diagnostic instruments. Paper diagnostics are simpler than their electronic counterparts due to a lack of technological competence, which has also contributed to the increased demand for the technology in more remote areas.

Global Paper Diagnostics Market Restraints

The lack of a particular regulatory framework and limited quantitative applications are restraining the market growth for paper diagnostics.

Global Paper Diagnostics Market Opportunities

• Technical advancements and government expenditure on R&D

Advances in printed electronics offer a suitable foundation to incorporate expanded functionality while preserving the accessibility and disposability of paper-based diagnostics. The development of a technologically superior paper-based sensor, the potential advantages of 3D wax printing techniques over traditional technologies, and related advantages, including their disposable nature and low cost of production, all contribute to the expansion of this business.

Paper-based sensors now deliver a solution to the sensing location using microfluidics, but more sophisticated devices use intricate 3-D geometries based on microfluidics. Additionally, the industry has been receiving a boost from rising government organization investments in R&D related to developing novel in vitro diagnostics tests and technologies. For instance, the European Diagnostic Manufacturers Association (EDMA) invests over € 1 billion annually in the research and development of in vitro diagnostics. It is dedicated to advancing and generally expanding Europe's in vitro diagnostic business.

Regional Analysis

The global paper diagnostics market is divided into North America, Europe, Asia-Pacific, South America and the Middle East & Africa based on the region.

The presence of key market participants in North America is primarily responsible for the region's dominance in the paper diagnostic industry. The market for technology investments, including high-definition techniques, is huge in North America. Because of the significant amount of government investment in the research and development industry. In addition to this, the incidence of cancer is significantly higher in American women.

The Asia-Pacific region now holds the second-largest share of the paper diagnostic market. It is anticipated to expand rapidly throughout the forthcoming time frame. The western and South-East Asia Pacific regions accounted for 63 per cent of all cases of tuberculosis that were found. In addition, nations such as China, Pakistan, India, Bangladesh, South Africa, and Indonesia are responsible for two-thirds of the newly reported disease cases throughout the projection period.

Segmental Analysis

The global paper diagnostics market is divided into five parts based on type, product, application, end-user and region.

Based on Type

The market is broken down into Diagnostic and Monitoring Devices. Diagnostic devices dominate the type sector of the paper diagnostic market. Diagnostic gadgets accounted for 50% of the market share in terms of revenue since they provide a cost-effective diagnosis. The market expansion of diagnostic devices is also supported by their flexibility, low equipment support requirements, and high adaptability.

The market is broken down into Lateral Flow Assays, Dipsticks, and Paper-Based Microfluidics based on product. Lateral flow assays dominate the paper diagnostic market's product sector. The market is expanding due to the rising prevalence of diseases like HIV, TB, and pneumonia and the expanded use of pregnancy test kits.

The market is broken down into Environmental Monitoring, Clinical Diagnostics (Cancer, Infectious Diseases, Liver disorders, others), and Food Quality Testing based on application. The clinical diagnostics segment dominated the market. Cancer deaths now account for 60% of all deaths worldwide, and they are dramatically increasing daily.

According to End-User

The market is divided into Home Healthcare, Assisted Living Healthcare Facilities, and hospitals and Clinics. The end-user market is dominated by home healthcare. The home healthcare sector's market expansion is driven by the expanded use of testing kits for conditions including diabetes and pregnancy.

The region divides the market into North America, Europe, Asia-Pacific, South America and the Middle East & Africa. North America dominated the market.